eu health priorities€¦ · members: professional bodies & pharmacists’ associations 2016:...

EU Health Priorities

Jurate SvarcaiteSecretary General PGEU

PGEU GPUE Pharmaceutical Group of European Union

Groupement Pharmaceutique de l’Union Européenne

AustriaBelgiumBulgariaCroatiaCyprusCzech RepDenmarkEstoniaFinlandFranceGermanyGreeceHungaryIrelandItalyLuxembourgMalta

NetherlandsPolandPortugalRomaniaSlovakiaSloveniaSpainSwedenUnited Kingdom

Bosnia HerzegovinaFYR MacedoniaNorwaySerbiaSwitzerlandTurkeyUkraine

Pharmaceutical Group of European UnionMembers: Professional Bodies & Pharmacists’ Associations

2016: 33 Countries

PGEU GPUE Pharmaceutical Group of European Union

Groupement Pharmaceutique de l’Union Européenne

1959 2016

400.000Community Pharmacists

160.000 Pharmacies

46 million

citizens visit a pharmacy every day

PGEU GPUE Pharmaceutical Group of European Union

Groupement Pharmaceutique de l’Union Européenne

Mission of PGEU

PGEU, as a a rigorous, proactive & constructive stakeholder:

Ensures our shared vision of Community Pharmacy is reflected in EU policy and legislative developments

Advocates for the contribution community pharmacists make to health systems and to public health through the provision of health services and the promotion of the rational and appropriate use of medicines

Promotes and develops cooperation in Community Pharmacy among the European nations

PGEU GPUE Pharmaceutical Group of European Union

Groupement Pharmaceutique de l’Union Européenne

How do we do this?

Working collaboratively with members to establish positions that reflect the view of the profession as a whole in Europe

Establishing & maintaining working relationships with other European & International stakeholders

Dedicated Secretariat who are central to the organisation

Keeping patient care as the central focus

PGEU GPUE Pharmaceutical Group of European Union

Groupement Pharmaceutique de l’Union Européenne

EU Health Law

EU: complementary competence in health

Focus on Public Health (Art 168 TFEU): limited powers ‘towards improving health and preventing disease”

Legal competencies: standard blood (organ) products, organs, tissues and medicines

Respecting the MS responsibilities for organisation, delivery and financing of medical care

PGEU GPUE Pharmaceutical Group of European Union

Groupement Pharmaceutique de l’Union Européenne

EU Single Market

Free movement:

People

Services

Goods

Capital

PGEU GPUE Pharmaceutical Group of European Union

Groupement Pharmaceutique de l’Union Européenne

PGEU is involved in a number of legal dossiers…

Professional Recognition

Directive

Falsified Medicines Directive

Medical Devices Regulation Health Claims on

Botanicals

Veterinary medicines

Trade Agreements VAT Waste Directive

PGEU GPUE Pharmaceutical Group of European Union

Groupement Pharmaceutique de l’Union Européenne

Professional Qualifications Recognition Directive (I)

PGEU GPUE Pharmaceutical Group of European Union

Groupement Pharmaceutique de l’Union Européenne

Professional Qualifications Recognition Directive (II)

The scope of pharmacist activities:

(a) preparation of the pharmaceutical form of medicinal products;

(b) manufacture and testing of medicinal products;

(c) testing of medicinal products in a laboratory for the testing of medicinal products;

(d) storage, preservation and distribution of medicinal products at the wholesale stage;

(e) supply, preparation, testing, storage, distribution and dispensing of safe and efficacious medicinal products of the required quality in pharmacies open to the public;

(f) preparation, testing, storage and dispensing of safe and efficacious medicinal products of the required quality in hospitals;

(g) provision of information and advice on medicinal products as such, including on their appropriate use;

(h) reporting of adverse reactions of pharmaceutical products to the competent authorities;

(i) personalised support for patients who administer their medication;

(j) contribution to local or national public health campaigns;

PGEU GPUE Pharmaceutical Group of European Union

Groupement Pharmaceutique de l’Union Européenne

Digital single market

PGEU GPUE Pharmaceutical Group of European Union

Groupement Pharmaceutique de l’Union Européenne

PGEU

PGEU GPUE Pharmaceutical Group of European Union

Groupement Pharmaceutique de l’Union Européenne

PGEU GPUE Pharmaceutical Group of European Union

Groupement Pharmaceutique de l’Union Européenne

AMR a major European challenge Why is AMR a serious threat to society and economy?

25 000 patients die annually in the EU alone as a result of infections caused by resistant bacteria.

€1.5 billion euros each year extra healthcare costs and productivity losses due to multidrug-resistant bacteria in the EU.

The consumption of specific antibiotics used for treatment of multidrug-resistant bacterial infections has increased significantly between 2010-2014.

Some good news - There has been a significant decrease in antibiotic consumption in the community in 5 countries (Denmark, Luxembourg, Slovenia, Spain and Sweden).

PGEU GPUE Pharmaceutical Group of European Union

Groupement Pharmaceutique de l’Union EuropéenneSource: http://ec.europa.eu/dgs/health_food-safety/amr/docs/eb445_amr_generalfactsheet_en.pdf

PGEU GPUE Pharmaceutical Group of European Union

Groupement Pharmaceutique de l’Union Européenne

Eurobarometer 2016

Source: http://ec.europa.eu/dgs/health_food-safety/amr/docs/eb445_amr_generalfactsheet_en.pdf

PGEU GPUE Pharmaceutical Group of European Union

Groupement Pharmaceutique de l’Union Européenne

EAAD

PGEU GPUE Pharmaceutical Group of European Union

Groupement Pharmaceutique de l’Union Européenne

National campaigns

PGEU GPUE Pharmaceutical Group of European Union

Groupement Pharmaceutique de l’Union Européenne

THANK YOUwww.pgeu.eu